News

November 18, 2016: PancreaSolve, Inc. gears for the critical in vitro validation of the in silico models at MD Anderson Cancer Center.

July 29, 2016: CytoSolve releases in silico models of pancreatic cancer stroma.

November 2, 2015: Dr. Anirban Maitra of MD Anderson Cancer Center joins the scientific advisory board of PancreaSolve, Inc.

November 2, 2015: Dr. Sunil Krishnan of MD Anderson Cancer Center joins the scientific advisory board of PancreaSolve, Inc.

November 1, 2015: PancreaSolve, Inc. gets exclusive license of CytoSolve’s in silico models of pancreatic cancer.

October 31, 2015: PancreaSolve, Inc. is incorporated as a Delaware corporation.

June 30, 2015: CytoSolve and MD Anderson Cancer Center join hands to advance cure strategies for pancreatic cancer.

November 10, 2013: CytoSolve’s combination drug therapy receives IND allowance from FDA in record 11 months.

June 10, 2013: CytoSolve releases in silico models of pancreatic cancer.